Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2294-2302
Published online before print April 21, 2003, doi: 10.1161/01.CIR.0000070596.30552.8B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/18/2294    most recent
01.CIR.0000070596.30552.8Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perin, E. C.
Right arrow Articles by Willerson, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perin, E. C.
Right arrow Articles by Willerson, J. T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bone Marrow Transplantation
*Heart Failure
Related Collections
Right arrow Angiogenesis
Right arrow Myogenesis
Right arrow Chronic ischemic heart disease

(Circulation. 2003;107:2294.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure

Emerson C. Perin, MD, PhD*; Hans F.R. Dohmann, MD*; Radovan Borojevic, PhD; Suzana A. Silva, MD; Andre L.S. Sousa, MD; Claudio T. Mesquita, MD, PhD; Maria I.D. Rossi, PhD; Antonio C. Carvalho, MD, PhD; Helio S. Dutra, PhD; Hans J.F. Dohmann, MD, PhD; Guilherme V. Silva, MD; Luciano Belém, MD; Ricardo Vivacqua, MD; Fernando O.D. Rangel, MD; Roberto Esporcatte, MD; Yong J. Geng, MD, PhD; William K. Vaughn, PhD; Joao A.R. Assad, MD; Evandro T. Mesquita, MD, PhD; James T. Willerson, MD

From the Texas Heart Institute at St Luke’s Episcopal Hospital, Houston, Tex (E.C.P., G.V.S., Y.J.G., W.K.V., J.T.W.); Hospital Procardiaco, Rio de Janeiro, Brazil (H.F.R.D., S.A.S., A.L.S.S., C.T.M., H.J.F.D., L.B., R.V., F.O.D.R., R.E., J.A.R.A., E.T.M.); Federal University, Rio de Janeiro, Brazil (R.B., M.I.D.R., A.C.C., H.S.D.); and Brazilian Millennium Institute for Tissue Bioengineering (H.F.R.D., R.B., A.C.C.).

Correspondence to Emerson C. Perin, MD, 6624 Fannin, Suite 2220, Houston, TX 77030 (e-mail eperin{at}crescentb.net), and Hans F.R. Dohmann, MD, Rua General Polidoro, 192, CEP 22080-000–Botafogo, Rio de Janeiro, Brazil (e-mail hemodinamica@procardiaco.com.br).

Background— This study evaluated the hypothesis that transendocardial injections of autologous mononuclear bone marrow cells in patients with end-stage ischemic heart disease could safely promote neovascularization and improve perfusion and myocardial contractility.

Methods and Results— Twenty-one patients were enrolled in this prospective, nonrandomized, open-label study (first 14 patients, treatment; last 7 patients, control). Baseline evaluations included complete clinical and laboratory evaluations, exercise stress (ramp treadmill), 2D Doppler echocardiogram, single-photon emission computed tomography perfusion scan, and 24-hour Holter monitoring. Bone marrow mononuclear cells were harvested, isolated, washed, and resuspended in saline for injection by NOGA catheter (15 injections of 0.2 cc). Electromechanical mapping was used to identify viable myocardium (unipolar voltage >=6.9 mV) for treatment. Treated and control patients underwent 2-month noninvasive follow-up, and treated patients alone underwent a 4-month invasive follow-up according to standard protocols and with the same procedures used as at baseline. Patient population demographics and exercise test variables did not differ significantly between the treatment and control groups; only serum creatinine and brain natriuretic peptide levels varied in laboratory evaluations at follow-up, being relatively higher in control patients. At 2 months, there was a significant reduction in total reversible defect and improvement in global left ventricular function within the treatment group and between the treatment and control groups (P=0.02) on quantitative single-photon emission computed tomography analysis. At 4 months, there was improvement in ejection fraction from a baseline of 20% to 29% (P=0.003) and a reduction in end-systolic volume (P=0.03) in the treated patients. Electromechanical mapping revealed significant mechanical improvement of the injected segments (P<0.0005) at 4 months after treatment.

Conclusions— Thus, the present study demonstrates the relative safety of intramyocardial injections of bone marrow–derived stem cells in humans with severe heart failure and the potential for improving myocardial blood flow with associated enhancement of regional and global left ventricular function.


Key Words: cells • heart failure • ischemia • revascularization • gene therapy




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
C.-F. Lam, P.-J. Chang, Y.-S. Huang, Y.-H. Sung, C.-C. Huang, M.-W. Lin, Y.-C. Liu, and Y.-C. Tsai
Prolonged Use of High-Dose Morphine Impairs Angiogenesis and Mobilization of Endothelial Progenitor Cells in Mice
Anesth. Analg., August 1, 2008; 107(2): 686 - 692.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. S. Penn and A. A. Mangi
Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy
Circ. Res., June 20, 2008; 102(12): 1471 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Tossios, B. Krausgrill, M. Schmidt, T. Fischer, M. Halbach, J. W.U. Fries, S. Fahnenstich, P. Frommolt, I. Heppelmann, A. Schmidt, et al.
Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction
Eur. Heart J., June 10, 2008; (2008) ehn218v1.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Dimmeler and A. Leri
Aging and Disease as Modifiers of Efficacy of Cell Therapy
Circ. Res., June 6, 2008; 102(11): 1319 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. Baldazzi, E. Jorgensen, R. S. Ripa, and J. Kastrup
Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route
Eur. Heart J., June 4, 2008; (2008) ehn233v1.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Smart and P. R. Riley
The Stem Cell Movement
Circ. Res., May 23, 2008; 102(10): 1155 - 1168.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Y. Tayyareci, M. Sezer, B. Umman, S. Besisik, A. Mudun, Y. Sanli, A. Oncul, N. Gurses, D. Sargin, M. Meric, et al.
Intracoronary Autologous Bone Marrow-Derived Mononuclear Cell Transplantation Improves Coronary Collateral Vessel Formation and Recruitment Capacity in Patients With Ischemic Cardiomyopathy: A Combined Hemodynamic and Scintigraphic Approach
Angiology, May 1, 2008; 59(2): 145 - 155.
[Abstract] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
K. V Arom, P. Ruengsakulrach, and V. Jotisakulratana
Intramyocardial Angiogenic Cell Precursor Injection for Cardiomyopathy
Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 143 - 148.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Kendziorra, H. Barthel, S. Erbs, F. Emmrich, R. Hambrecht, G. Schuler, O. Sabri, and R. Kluge
Effect of Progenitor Cells on Myocardial Perfusion and Metabolism in Patients After Recanalization of a Chronically Occluded Coronary Artery
J. Nucl. Med., April 1, 2008; 49(4): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
Bioscience HorizonsHome page
K. Kaczmarczyk
Is the clinical use of adult stem cells a realistic possibility for myocardial regeneration?
Bioscience Horizons, March 1, 2008; 1(1): 67 - 74.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. K. Burt, Y. Loh, W. Pearce, N. Beohar, W. G. Barr, R. Craig, Y. Wen, J. A. Rapp, and J. Kessler
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
JAMA, February 27, 2008; 299(8): 925 - 936.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kubo, T.-S. Li, R. Suzuki, B. Shirasawa, N. Morikage, M. Ohshima, S.-L. Qin, and K. Hamano
Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H590 - H595.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. O. Traktuev, S. Merfeld-Clauss, J. Li, M. Kolonin, W. Arap, R. Pasqualini, B. H. Johnstone, and K. L. March
A Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize Endothelial Networks
Circ. Res., January 4, 2008; 102(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
K. A. Horvath and Y. Zhou
Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow
Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752.
[Full Text]


Home page
Card Surg AdultHome page
R. P. Gallegos and R. M. Bolman III
Stem Cell Induced Regeneration of Myocardium
Card. Surg. Adult, January 1, 2008; 3(2008): 1657 - 1668.
[Full Text]


Home page
Stem CellsHome page
R. Madonna, J. T. Willerson, and Y.-J. Geng
Myocardin A Enhances Telomerase Activities in Adipose Tissue Mesenchymal Cells and Embryonic Stem Cells Undergoing Cardiovascular Myogenic Differentiation
Stem Cells, January 1, 2008; 26(1): 202 - 211.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H.-F. Tse, S. Thambar, Y.-L. Kwong, P. Rowlings, G. Bellamy, J. McCrohon, P. Thomas, B. Bastian, J. K.F. Chan, G. Lo, et al.
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial)
Eur. Heart J., December 2, 2007; 28(24): 2998 - 3005.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Tongers and D. W. Losordo
Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2843 - 2852.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. N. Ebert, D. G. Taylor, H.-L. Nguyen, D. P. Kodack, R. J. Beyers, Y. Xu, Z. Yang, and B. A. French
Noninvasive Tracking of Cardiac Embryonic Stem Cells In Vivo Using Magnetic Resonance Imaging Techniques
Stem Cells, November 1, 2007; 25(11): 2936 - 2944.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Ripa, M. Haack-Sorensen, Y. Wang, E. Jorgensen, S. Mortensen, L. Bindslev, T. Friis, and J. Kastrup
Bone Marrow Derived Mesenchymal Cell Mobilization by Granulocyte-Colony Stimulating Factor After Acute Myocardial Infarction: Results From the Stem Cells in Myocardial Infarction (STEMMI) Trial
Circulation, September 11, 2007; 116(11_suppl): I-24 - I-30.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Li, P. Atmaca-Sonmez, C. L. Schanie, S. T. Ildstad, H. J. Kaplan, and V. Enzmann
Endogenous Bone Marrow Derived Cells Express Retinal Pigment Epithelium Cell Markers and Migrate to Focal Areas of RPE Damage
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4321 - 4327.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. C. Wu, F. M. Bengel, and S. S. Gambhir
Cardiovascular Molecular Imaging
Radiology, August 1, 2007; 244(2): 337 - 355.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. E. Ip, Y. Wu, J. Huang, L. Zhang, R. E. Pratt, and V. J. Dzau
Mesenchymal Stem Cells Use Integrin beta1 Not CXC Chemokine Receptor 4 for Myocardial Migration and Engraftment
Mol. Biol. Cell, August 1, 2007; 18(8): 2873 - 2882.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
H. Aupperle, J. Garbade, A. Schubert, M. Barten, S. Dhein, H.-A Schoon, and F.-W Mohr
Effects of Autologous Stem Cells on Immunohistochemical Patterns and Gene Expression of Metalloproteinases and Their Tissue Inhibitors in Doxorubicin Cardiomyopathy in a Rabbit Model
Vet. Pathol., July 1, 2007; 44(4): 494 - 503.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Sudo, M. Kanno, K. Miharada, S. Ogawa, T. Hiroyama, K. Saijo, and Y. Nakamura
Mesenchymal Progenitors Able to Differentiate into Osteogenic, Chondrogenic, and/or Adipogenic Cells In Vitro Are Present in Most Primary Fibroblast-Like Cell Populations
Stem Cells, July 1, 2007; 25(7): 1610 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. K. Cheng, T. Asai, H. Tang, N. H. Dashoush, R. J. Kara, K. D. Costa, Y. Naka, E. X. Wu, D. J. Wolgemuth, and H. W. Chaudhry
Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction and Prevents Heart Failure
Circ. Res., June 22, 2007; 100(12): 1741 - 1748.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
H.-F. Tse and C.-P. Lau
Therapeutic Angiogenesis With Bone Marrow--Derived Stem Cells
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 89 - 97.
[Abstract] [PDF]


Home page
Stem CellsHome page
S. Baba, T. Heike, K. Umeda, T. Iwasa, S. Kaichi, Y. Hiraumi, H. Doi, M. Yoshimoto, M. Kanatsu-Shinohara, T. Shinohara, et al.
Generation of Cardiac and Endothelial Cells from Neonatal Mouse Testis-Derived Multipotent Germline Stem Cells
Stem Cells, June 1, 2007; 25(6): 1375 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kubo, T.-S. Li, R. Suzuki, M. Ohshima, S.-L. Qin, and K. Hamano
Short-term pretreatment with low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2582 - H2588.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Ohnishi, T. Yasuda, S. Kitamura, and N. Nagaya
Effect of Hypoxia on Gene Expression of Bone Marrow-Derived Mesenchymal Stem Cells and Mononuclear Cells
Stem Cells, May 1, 2007; 25(5): 1166 - 1177.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fukushima, A. Varela-Carver, S. R. Coppen, K. Yamahara, L. E. Felkin, J. Lee, P. J.R. Barton, C. M.N. Terracciano, M. H. Yacoub, and K. Suzuki
Direct Intramyocardial But Not Intracoronary Injection of Bone Marrow Cells Induces Ventricular Arrhythmias in a Rat Chronic Ischemic Heart Failure Model
Circulation, May 1, 2007; 115(17): 2254 - 2261.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. S. Penn
Patient and Cellular Characteristics Determine Efficacy of Cell Therapy
Circ. Res., April 27, 2007; 100(8): 1101 - 1103.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. L.M.A. Beeres, F. M. Bengel, J. Bartunek, D. E. Atsma, J. M. Hill, M. Vanderheyden, M. Penicka, M. J. Schalij, W. Wijns, and J. J. Bax
Role of Imaging in Cardiac Stem Cell Therapy
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1137 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. J. Lee, Q. Fang, P. A. Davol, Y. Gu, R. E. Sievers, R. C. Grabert, J. M. Gall, E. Tsang, M. S. Yee, H. Fok, et al.
Antibody Targeting of Stem Cells to Infarcted Myocardium
Stem Cells, March 1, 2007; 25(3): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. R. Smith, L. Barile, H. C. Cho, M. K. Leppo, J. M. Hare, E. Messina, A. Giacomello, M. R. Abraham, and E. Marban
Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens
Circulation, February 20, 2007; 115(7): 896 - 908.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. de Silva, L. F. Gutierrez, A. N. Raval, E. R. McVeigh, C. Ozturk, and R. J. Lederman
X-Ray Fused With Magnetic Resonance Imaging (XFM) to Target Endomyocardial Injections: Validation in a Swine Model of Myocardial Infarction
Circulation, November 28, 2006; 114(22): 2342 - 2350.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kawamoto, H. Iwasaki, K. Kusano, T. Murayama, A. Oyamada, M. Silver, C. Hulbert, M. Gavin, A. Hanley, H. Ma, et al.
CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells
Circulation, November 14, 2006; 114(20): 2163 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. A. Pijnappels, M. J. Schalij, J. van Tuyn, D. L. Ypey, A. A.F. de Vries, E. E. van der Wall, A. van der Laarse, and D. E. Atsma
Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling
Cardiovasc Res, November 1, 2006; 72(2): 282 - 291.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Rosen
Are Stem Cells Drugs?: The Regulation of Stem Cell Research and Development
Circulation, October 31, 2006; 114(18): 1992 - 2000.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Ben-Dor, S. Fuchs, and R. Kornowski
Potential Hazards and Technical Considerations Associated With Myocardial Cell Transplantation Protocols for Ischemic Myocardial Syndrome
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1519 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K.-L. Ang, L. Takura Shenje, L. Srinivasan, and M. Galinanes
Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1549 - 1558.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Honold, R. Lehmann, C. Heeschen, D. H. Walter, B. Assmus, K.-I. Sasaki, H. Martin, J. Haendeler, A. M. Zeiher, and S. Dimmeler
Effects of Granulocyte Colony Stimulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2238 - 2243.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Goussetis, A. Manginas, M. Koutelou, I. Peristeri, M. Theodosaki, N. Kollaros, E. Leontiadis, A. Theodorakos, G. Paterakis, G. Karatasakis, et al.
Intracoronary Infusion of CD133+ and CD133-CD34+ Selected Autologous Bone Marrow Progenitor Cells in Patients with Chronic Ischemic Cardiomyopathy: Cell Isolation, Adherence to the Infarcted Area, and Body Distribution
Stem Cells, October 1, 2006; 24(10): 2279 - 2283.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-i. Sasaki, C. Heeschen, A. Aicher, T. Ziebart, J. Honold, C. Urbich, L. Rossig, U. Koehl, M. Koyanagi, A. Mohamed, et al.
Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy
PNAS, September 26, 2006; 103(39): 14537 - 14541.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Madonna, L. Rinaldi, C. Rossi, Y.-J. Geng, and R. De Caterina
Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells
Eur. Heart J., September 1, 2006; 27(17): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
O. Caspi and L. Gepstein
Stem cells for myocardial repair
Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E43 - E54.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. S. Ripa, Y. Wang, E. Jorgensen, H. E. Johnsen, B. Hesse, and J. Kastrup
Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease
Eur. Heart J., August 1, 2006; 27(15): 1785 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Takahashi, T.-S. Li, R. Suzuki, T. Kobayashi, H. Ito, Y. Ikeda, M. Matsuzaki, and K. Hamano
Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H886 - H893.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. J. Stuckey, C. A. Carr, E. Martin-Rendon, D. J. Tyler, C. Willmott, P. J. Cassidy, S. J.M. Hale, J. E. Schneider, L. Tatton, S. E. Harding, et al.
Iron Particles for Noninvasive Monitoring of Bone Marrow Stromal Cell Engraftment into, and Isolation of Viable Engrafted Donor Cells from, the Heart
Stem Cells, August 1, 2006; 24(8): 1968 - 1975.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Boyle, S. P. Schulman, and J. M. Hare
Stem Cell Therapy for Cardiac Repair: Ready for the Next Step
Circulation, July 25, 2006; 114(4): 339 - 352.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kobayashi, T. Kondo, N. Inoue, M. Aoki, M. Mizuno, K. Komori, J. Yoshida, and T. Murohara
Combination of In Vivo Angiopoietin-1 Gene Transfer and Autologous Bone Marrow Cell Implantation for Functional Therapeutic Angiogenesis
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1465 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T.-S. Li, M. Takahashi, R. Suzuki, T. Kobayashi, H. Ito, A. Mikamo, and K. Hamano
Pravastatin Improves Remodeling and Cardiac Function After Myocardial Infarction by an Antiinflammatory Mechanism Rather than by the Induction of Angiogenesis
Ann. Thorac. Surg., June 1, 2006; 81(6): 2217 - 2225.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. E. Murry, H. Reinecke, and L. M. Pabon
Regeneration Gaps: Observations on Stem Cells and Cardiac Repair
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785.